- Home
- XERS vs ECPG Comparison
XERS vs ECPG Comparison
Compare XERS & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | ECPG |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | XERS | ECPG |
|---|---|---|
| Price | $6.67 | $58.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $10.43 | ★ $64.67 |
| AVG Volume (30 Days) | ★ 1.4M | 128.8K |
| Earning Date | 03-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.78 | ★ 33.14 |
| EPS | N/A | ★ 7.57 |
| Revenue | $49,590,000.00 | ★ $1,316,361,000.00 |
| Revenue This Year | $44.77 | $33.09 |
| Revenue Next Year | $27.72 | $2.34 |
| P/E Ratio | ★ N/A | $7.72 |
| Revenue Growth | ★ 142.67 | 7.66 |
| 52 Week Low | $3.58 | $26.45 |
| 52 Week High | $10.08 | $59.59 |
Technical Indicators
Market Signals| Indicator | XERS | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | 58.86 |
| Support Level | $6.26 | $55.90 |
| Resistance Level | $7.07 | $59.59 |
| Average True Range (ATR) | 0.32 | 1.51 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 25.94 | 66.68 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.